Baseline characteristics of the 42 patients with SNV with longterm followup. Data are no. (%) or median (range) as appropriate.
| Features | All Patients, n = 42 |
|---|---|
| Demography | |
| Median age, yrs | 54 (21–82) |
| Male | 27 (64) |
| Systemic necrotizing vasculitides | |
| GPA | 20 (48) |
| EGPA | 9 (21) |
| MPA | 8 (19) |
| PAN | 5 (12) |
| Laboratory features | |
| Median fibrinogen, g/l | 3.5 (2.2–6.8) |
| Median CRP, mg/l | 4.4 (0.2–49) |
| CRP ≥ 5 mg/l | 20 (48) |
| CV risk factors | |
| Hypertension | 22 (52) |
| Median total cholesterol, mmol/l | 5.3 (3.2–8.3) |
| Median LDL cholesterol, mmol/l | 3.8 (2.1–6.2) |
| Smoking | 9 (21) |
| Diabetes | 1 (2) |
| BMI > 30 kg/m2 | 6 (14) |
| Known history of CV disease | 7 (17) |
| 10-year Framingham risk score ≥ 20% | 5 (12) |
| High-risk status | 12 (29) |
Diabetes is defined as fasting glucose ≥ 7 mmol/l. SNV: systemic necrotizing vasculitides; GPA: granulomatosis with polyangiitis; EGPA: eosinophilic GPA; MPA: microscopic polyangiitis; PAN: polyarteritis nodosa; CRP: C-reactive protein; CV: cardiovascular; BMI: body mass index.